Smartlab Europe

News

Leading BioPharma consultancy SmartAnalyst appoints new CEO

SmartAnalyst, an Ashfield Advisory company, part of UDG Healthcare plc., has appointed Sasha Richardson as Chief Executive Officer. With 24 years’ experience, most recently as a Managing Director and senior leader in Ernst and Young’s Health Sciences & Wellness practice,...

IDBS and Scitara announce a strategic partnership to integrate the Scitara Digital Lab Exchange platform with Polar, IDBS’ Biopharmaceutical Lifecycle Management platform

IDBS, a leading innovator in Biopharmaceutical Lifecycle Management (BPLM), and Scitara, a pioneer in laboratory IoT, have entered into a strategic partnership to create a combined solution that will significantly extend IDBS Polar BPLM’s laboratory data connectivity and instrument...

Sound Pharmaceuticals to launch NIH-funded Covid-19 oral therapeutic trial

Developed for various neurotologic, neuropsychiatric, and respiratory indications, SPI-1005 is a capsule with a small molecule called ebselen. The latest development comes after Sound Pharmaceuticals received a Cooperative Grant award worth $3.1m from the US National Institutes of Health (NIH)...

UK begins rollout of Moderna vaccine against COVID-19 in Wales

Moderna’s Covid-19 vaccine rollout has begun in the UK, where patients in Wales have been the first to receive a dose. Supplies arrived in Wales  with 5,000 doses having been delivered to vaccination centres across Carmarthenshire, Ceredigion and Pembrokeshire....

Peli BioThermal Adds Module in School of Cool Online Learning Platform

Peli BioThermal, the global name in temperature controlled solutions, announces a new module available now on its School of Cool™ online learning platform. The newest module available in the platform introduces customers and distributors to reusable and single-use shippers,...

Hitachi and Axcelead to start joint development of solutions for the efficient creation of next-generation biopharmaceuticals

Hitachi, Ltd. announced that they have agreed on a comprehensive collaborative partnership to develop solutions contributing on more efficient creation of next-generation biopharmaceuticals with digital technology and drug discovery platform. Hitachi has also made investment to Drug Discovery Gateway...

AB Science and University of Chicago to develop Covid-19 drugs

AB Science SA, together with the University of Chicago, announces the signing of an exclusive licensing agreement for conducting research on the prevention and treatment of humans infected with nidoviruses, coronaviruses and picornaviruses. This collaboration follows the discovery by the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »